These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2067442)

  • 21. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Mizuta E; Yamasaki S; Nakatake M; Kuno S
    Neurology; 1993 May; 43(5):1048-9. PubMed ID: 7605396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 73-year-old woman with confusion, rigidity, and fever.
    Altus P; Weissman MS; Hencey MA
    Hosp Pract (Off Ed); 1991 Jun; 26(6):97-8, 100. PubMed ID: 2040682
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study.
    Takubo H; Shimoda-Matsubayashi S; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S43-6. PubMed ID: 12735914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Rascol O; Salachas F; Montastruc JL
    Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhabdomyolysis as a complication of Parkinson's disease].
    Pozzoni P; Tentori F; Corti M; Pozzi C
    G Ital Nefrol; 2002; 19(1):13-7. PubMed ID: 12165940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
    Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
    Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 30. Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
    Ozer F; Meral H; Aydin B; Hanoglu L; Aydemir T; Oral T
    J ECT; 2005 Jun; 21(2):125-7. PubMed ID: 15905757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome in parkinsonian patients: risk factors.
    Kuno S; Mizuta E; Yamasaki S
    Eur Neurol; 1997; 38 Suppl 2():56-9. PubMed ID: 9387804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
    Hashimoto T; Tokuda T; Hanyu N; Tabata K; Yanagisawa N
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S25-30. PubMed ID: 12735912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa withdrawal and the neuroleptic malignant syndrome.
    Sandyk R; Iacono RP
    Postgrad Med J; 1986 Jul; 62(729):701-1. PubMed ID: 3748941
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Sato Y; Asoh T; Metoki N; Satoh K
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):574-6. PubMed ID: 12700295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal hyperpyrexia after withdrawal of levodopa.
    Sechi GP; Tanda F; Mutani R
    Neurology; 1984 Feb; 34(2):249-51. PubMed ID: 6538021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group.
    Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.
    Takubo H; Harada T; Hashimoto T; Inaba Y; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S31-41. PubMed ID: 12735913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine].
    Hamada Y; Miyamoto K; Inatsugi Y; Suzuki H; Kusunoki S
    Rinsho Shinkeigaku; 2006 Aug; 46(8):575-8. PubMed ID: 17154040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.